Influenza
Showing NaN - NaN of 91
SARS-CoV-2, Influenza Trial in Canada, United States (mRNA-1083, Placebo, Influenza Vaccine)
Not yet recruiting
- SARS-CoV-2
- Influenza
- mRNA-1083
- +3 more
-
Anniston, Alabama
- +172 more
Oct 18, 2023
SARS-CoV-2, Influenza Trial in United States (Fluarix, mRNA-1083.1, mRNA-1083.2)
Recruiting
- SARS-CoV-2
- Influenza
- Fluarix
- +8 more
-
Chandler, Arizona
- +68 more
Apr 24, 2023
Influenza, Influenza -Like Illness Trial in United States (Norketotifen, Placebo)
Completed
- Influenza
- Influenza -Like Illness
- Norketotifen
- Placebo
-
Phoenix, Arizona
- +19 more
Jan 25, 2023
SARS-CoV-2, Influenza, RSV Trial in Australia, United Kingdom, United States (mRNA-1010, mRNA-1345, mRNA-1273.214)
Recruiting
- SARS-CoV-2
- +2 more
- mRNA-1010
- +4 more
-
DeLand, Florida
- +29 more
Jan 23, 2023
Influenza Trial in Worldwide (Baloxavir Marboxil, Placebo)
Recruiting
- Influenza
- Baloxavir Marboxil
- Placebo
-
Birmingham, Alabama
- +290 more
Jan 20, 2023
Influenza Trial in Worldwide (Baloxavir Marboxil)
Recruiting
- Influenza
- Baloxavir Marboxil
-
Birmingham, Alabama
- +46 more
Jan 11, 2023
SARS-CoV-2, Influenza Trial in United States (mRNA-1073, mRNA-1010, mRNA-1273)
Active, not recruiting
- SARS-CoV-2
- Influenza
- mRNA-1073
- +3 more
-
Hollywood, Florida
- +13 more
Oct 5, 2022
Gut Microbiome and Dietary Determinants and Vaccine Response
Recruiting
- Influenza
- Biospecimen Collection
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Jun 28, 2022
Influenza Trial in United Kingdom, United States (Fluzone Quadrivalent vaccine, No Preservative)
Completed
- Influenza
- Fluzone Quadrivalent vaccine, No Preservative
-
Birmingham, Alabama
- +35 more
Mar 15, 2022
Influenza, Influenza Immunisation Trial in United States (AF03, Delta Inulin-CpG55.2, Influenza Virus Quadrivalent Inactivated
HIV, Influenza Trial in Puerto Rico, United States (Cold-adapted live attenuated influenza vaccine (FluMist), Inactivated
Completed
- HIV Infections
- Influenza
- Cold-adapted live attenuated influenza vaccine (FluMist)
- Inactivated influenza vaccine (IAIV)
-
Birmingham, Alabama
- +60 more
Oct 28, 2021
Influenza Trial in Worldwide (Liquid CAIV-T)
Completed
- Influenza
- Liquid CAIV-T
-
Hoover, Alabama
- +160 more
Sep 10, 2021
Hematopoietic and Lymphoid Cell Tumor, Influenza Trial in Houston (Baloxavir Marboxil, Oseltamivir)
Not yet recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Influenza
- Baloxavir Marboxil
- Oseltamivir
-
Houston, TexasM D Anderson Cancer Center
Jan 13, 2021
Influenza Trial in Houston, Gießen (Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_0%MF59, Cell Culture-Derived H5N1
Completed
- Influenza
- Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_0%MF59
- +11 more
-
Houston, Texas
- +1 more
Aug 20, 2020
Influenza, Influenza Immunisation Trial in Iowa City, Cincinnati, Houston (Influenza Multimeric-001 Vaccine, Placebo,
Completed
- Influenza
- Influenza Immunisation
- Influenza Multimeric-001 Vaccine
- +2 more
-
Iowa City, Iowa
- +2 more
Jun 2, 2020
Influenza Trial in Worldwide (Baloxavir Marboxil, Oseltamivir)
Influenza, Respiratory Syncytial Viruses, Paramyxoviridae Infections Trial in United States (N95 Respirator, Medical/surgical
Completed
- Influenza
- +4 more
- N95 Respirator
- Medical/surgical mask
-
Aurora, Colorado
- +6 more
Apr 3, 2019
Influenza Trial in Worldwide (Amantadine, Ribavirin, Oseltamivir, Oseltamivir)
Completed
- Influenza
- Amantadine, Ribavirin, Oseltamivir
- Oseltamivir
-
Birmingham, Alabama
- +90 more
Jan 31, 2019
Influenza Trial in United States (GSK investigational vaccine GSK1557482A, Fluzone®)
Completed
- Influenza
- GSK investigational vaccine GSK1557482A
- Fluzone®
-
Birmingham, Alabama
- +27 more
Aug 22, 2018